To assess the relative levels of uPA and PAI-1 in human fibrotic lung disease, we measured their levels in primary lung fibroblasts derived from patients with SSc who had pulmonary fibrosis (PF) and patients with IPF. The gene discussed is SERPINE1; the disease is systemic sclerosis.